Capricor Therapeutics Inc (NASDAQ: CAPR) is 285.48% higher on its value in year-to-date trading and has touched a low of $2.68 and a high of $23.40 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CAPR stock was last observed hovering at around $18.23 in the last trading session, with the day’s gains setting it 0.62%.
Currently trading at $18.85, the stock is -5.84% and 39.54% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.08 million and changing 3.40% at the moment leaves the stock 163.55% off its SMA200. CAPR registered 559.09% gain for a year compared to 6-month gain of 247.79%. The firm has a 50-day simple moving average (SMA 50) of $13.226 and a 200-day simple moving average (SMA200) of $7.07875.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.90% loss in the last 1 month and extending the period to 3 months gives it a 401.33%, and is -6.22% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.23% over the week and 10.90% over the month.
Capricor Therapeutics Inc (CAPR) has around 102 employees, a market worth around $856.98M and $27.15M in sales. Profit margin for the company is -102.93%. Distance from 52-week low is 603.36% and -19.44% from its 52-week high. The company has generated returns on investments over the last 12 months (-175.51%).
The EPS is expected to shrink by -50.00% this year
88.0 institutions hold shares in Capricor Therapeutics Inc (CAPR), with institutional investors hold 24.84% of the company’s shares. The shares outstanding are 45.46M, and float is at 37.83M with Short Float at 16.34%. Institutions hold 20.61% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.63 million shares valued at $7.77 million. The investor’s holdings represent 5.194 of the CAPR Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.55 million shares valued at $7.39 million to account for 4.9401 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.64 million shares representing 2.0462 and valued at over $3.06 million, while MILLENNIUM MANAGEMENT LLC holds 1.5293 of the shares totaling 0.48 million with a market value of $2.29 million.
Capricor Therapeutics Inc (CAPR) Insider Activity
The most recent transaction is an insider purchase by Nippon Shinyaku Co Ltd, the company’s 10% Owner. SEC filings show that Nippon Shinyaku Co Ltd bought 2,798,507 shares of the company’s common stock on Sep 20 ’24 at a price of $5.36 per share for a total of $15.0 million. Following the purchase, the insider now owns 7.09 million shares.
